LONG BEACH, Calif.----Obagi Medical Products, Inc. today reported net revenue for the fourth quarter ended December 31, 2009 rose 21% to $30.7 million, from $25.4 million in the fourth quarter of 2008.
Today GenVec, Inc. announced financial results for the fourth quarter and year ended December 31, 2009. For the year ended December 31, 2009, the Company reported a net loss of $18.4 million, or $0.19 per share, compared with a net loss of $26.1 million, or $0.31 per share for the year ended December 31, 2008.
Optimer Pharmaceuticals, Inc. today announced 2009 fourth quarter and full year financial results and accomplishments.
Comment Wall (2 comments)
You need to be a member of SciBog: Science & Medical Writing Blogs to add comments!
Join SciBog: Science & Medical Writing Blogs